Literature DB >> 15123722

Ectodomain shedding of SHPS-1 and its role in regulation of cell migration.

Hiroshi Ohnishi1, Hisae Kobayashi, Hideki Okazawa, Yoshihide Ohe, Kyoko Tomizawa, Ryuji Sato, Takashi Matozaki.   

Abstract

SHPS-1 is a transmembrane protein whose cytoplasmic region undergoes tyrosine phosphorylation and then binds the protein-tyrosine phosphatase SHP-2. Formation of the SHPS-1-SHP-2 complex is implicated in regulation of cell migration. In addition, SHPS-1 and its ligand CD47 constitute an intercellular recognition system that contributes to inhibition of cell migration by cell-cell contact. The ectodomain of SHPS-1 has now been shown to be shed from cells in a reaction likely mediated by a metalloproteinase. This process was promoted by activation of protein kinase C or of Ras, and the released ectodomain exhibited minimal CD47-binding activity. Metalloproteinases catalyzed the cleavage of a recombinant SHPS-1-Fc fusion protein in vitro, and the primary cleavage site was localized to the juxtamembrane region of SHPS-1. Forced expression of an SHPS-1 mutant resistant to ectodomain shedding impaired cell migration, cell spreading, and reorganization of the actin cytoskeleton. It also increased the tyrosine phosphorylation of paxillin and FAK triggered by cell adhesion. These results suggest that shedding of the ectodomain of SHPS-1 plays an important role in regulation of cell migration and spreading by this protein.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15123722     DOI: 10.1074/jbc.M313085200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

Review 1.  Molecular and cellular mechanisms of ectodomain shedding.

Authors:  Kazutaka Hayashida; Allison H Bartlett; Ye Chen; Pyong Woo Park
Journal:  Anat Rec (Hoboken)       Date:  2010-06       Impact factor: 2.064

Review 2.  Matrix metalloproteinase dependent cleavage of cell adhesion molecules in the pathogenesis of CNS dysfunction with HIV and methamphetamine.

Authors:  Katherine Conant; Seung T Lim; Brad Randall; Kathleen A Maguire-Zeiss
Journal:  Curr HIV Res       Date:  2012-07       Impact factor: 1.581

3.  Prolactin receptor-integrin cross-talk mediated by SIRPα in breast cancer cells.

Authors:  Traci Galbaugh; Yvonne B Feeney; Charles V Clevenger
Journal:  Mol Cancer Res       Date:  2010-09-08       Impact factor: 5.852

4.  The role of cis dimerization of signal regulatory protein alpha (SIRPalpha) in binding to CD47.

Authors:  Winston Y Lee; Dominique A Weber; Oskar Laur; Sean R Stowell; Ingrid McCall; Rakieb Andargachew; Richard D Cummings; Charles A Parkos
Journal:  J Biol Chem       Date:  2010-09-07       Impact factor: 5.157

5.  Signal regulatory proteins (SIRPS) are secreted presynaptic organizing molecules.

Authors:  Hisashi Umemori; Joshua R Sanes
Journal:  J Biol Chem       Date:  2008-09-26       Impact factor: 5.157

Review 6.  Glial activation and matrix metalloproteinase release in cerebral malaria.

Authors:  A Szklarczyk; M Stins; E A Milward; H Ryu; C Fitzsimmons; D Sullivan; K Conant
Journal:  J Neurovirol       Date:  2007       Impact factor: 2.643

7.  Cleavage of Signal Regulatory Protein α (SIRPα) Enhances Inflammatory Signaling.

Authors:  James D Londino; Dexter Gulick; Jeffrey S Isenberg; Rama K Mallampalli
Journal:  J Biol Chem       Date:  2015-11-03       Impact factor: 5.157

8.  The absence of CD47 promotes nerve fiber growth from cultured ventral mesencephalic dopamine neurons.

Authors:  Franziska Marschinke; Sanaz Hashemian; Takashi Matozaki; Per-Arne Oldenborg; Ingrid Strömberg
Journal:  PLoS One       Date:  2012-09-26       Impact factor: 3.240

9.  Synapse maturation by activity-dependent ectodomain shedding of SIRPα.

Authors:  Anna B Toth; Akiko Terauchi; Lily Y Zhang; Erin M Johnson-Venkatesh; David J Larsen; Michael A Sutton; Hisashi Umemori
Journal:  Nat Neurosci       Date:  2013-09-15       Impact factor: 24.884

Review 10.  Original insights on thrombospondin-1-related antireceptor strategies in cancer.

Authors:  Albin Jeanne; Christophe Schneider; Laurent Martiny; Stéphane Dedieu
Journal:  Front Pharmacol       Date:  2015-10-29       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.